Krilogy Financial LLC Lexicon Pharmaceuticals, Inc. Transaction History

Krilogy Financial LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$6.15 - $10.51 $3,075 - $5,255	-500 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$10.32 - $13.06 $5,160 - $6,530	500 New	500 $5,000
Q2 2018 Aug 15, 2018	SELL	$7.8 - $13.69 $3,900 - $6,845	-500 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$8.77 - $12.28 $2,631 - $3,684	-300 Reduced 37.5%	500 $5,000
Q2 2017 Aug 15, 2017	BUY	N/A	800	800 $13,000

141

238M

459K

133K

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $157M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

Get notified when there are updates to the investment portfolio of Krilogy Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Krilogy Financial LLC with notifications on news.